What Next Dimension (NeD) does

Next Dimension (NeD) is a privately held Israeli medical device company developing Retinal Spectral Imaging Systems intended for the early diagnosis of vision-threatening diseases. The company's core product is a spectral imaging device designed to capture multi-wavelength retinal data to enable earlier detection of ocular pathology compared to conventional fundus imaging. The intended end users are eye care professionals such as ophthalmologists and optometrists operating in clinical settings where early detection of retinal disease drives better patient outcomes.

Founded in 2005 and headquartered in Ofakim, Israel, the company operates with a small team of 1–10 employees as a private for-profit entity. The company is listed as a portfolio company of OHV Ventures, an Israeli venture capital firm, based on the website URL pattern (ohv.co.il/asp/portfolio_company.asp?id=123), indicating institutional backing, though no funding rounds, amounts, or investor details are disclosed in the source material. The company has no publicly disclosed revenue, named customers, distribution partnerships, or pricing model, and no management team composition is available in the source data.

The supporting source material provided is largely about an unrelated Israeli moving services business (MoversTLV / Afterio Ltd.), indicating a data sourcing error. The analysis below is grounded in the firmographic definition provided and is necessarily limited in its conclusions due to the absence of substantive company-specific data such as funding history, clinical validation milestones, regulatory clearances (FDA/CE), customer references, or commercialization metrics.

Name

Next Dimension (NeD)

Legal name

Afterio Ltd. (אפטריו בעמ)

Website

https://ohv.co.il

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

Next Dimension (NeD) is an Israeli medical device company developing Retinal Spectral Imaging Systems for early diagnosis of vision-threatening diseases. Founded in 2005 in Ofakim, the private firm operates with 1–10 employees and is part of the OHV Ventures portfolio.

Ownership category

akta.pro rank

Product category

Ophthalmic Diagnostic Imaging

NAICS

Ophthalmic Goods Manufacturing (339115)

SIC

Optical Instruments & Lenses (3827), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography) (HLAHAJAB)

Keywords

• Retinal spectral imaging
• Ophthalmic diagnostic imaging
• Vision disease screening
• Medical imaging systems
• Retinal disease diagnosis

Headquarters

HQ city

Ofakim

HQ country

Israel

HQ region

Middle East

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Core offering

Next Dimension (NeD) provides a Retinal Spectral Imaging System. The system is intended for the early diagnosis of vision-threatening diseases.

Differentiator

Problem solved

Functional benefit

Products and services

• Retinal Spectral Imaging System A retinal spectral imaging system intended for the early diagnosis of vision-threatening diseases.

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Mediwhale: Mediwhale develops AI-based retinal imaging diagnostics (Reti-CVD, DrNoon) for systemic disease risk assessment, an emerging peer applying image-based analytics to the same retinal-imaging modality.
• Eyenuk: Eyenuk develops AI-enabled retinal image analysis (EyeArt) for autonomous detection of diabetic retinopathy, an emerging player applying novel technology (AI/spectral) to the same early-detection mission as NeD.
• Digital Diagnostics (IDx-DR): Digital Diagnostics built IDx-DR, an autonomous AI diagnostic system for diabetic retinopathy, an emerging adjacent competitor operating in the same disease-detection space with a software-only approach.

Broad incumbents

• Carl Zeiss Meditec: Zeiss Meditec offers the Cirrus HD-OCT and a broad portfolio of ophthalmic diagnostic and surgical devices, serving the same retinal imaging customer base as NeD but at vastly greater scale across multiple product lines.
• Topcon Healthcare: Topcon's 3D-OCT and Maestro systems are widely deployed retinal imaging products used by ophthalmologists and optometrists, overlapping directly with NeD's customer use case while operating across a much broader eyecare portfolio.
• Nidek: Nidek manufactures OCT and fundus imaging devices sold into ophthalmology clinics worldwide, making it a comparable hardware vendor serving the same diagnostic imaging workflow that NeD's spectral system targets.

Direct peers

• Heidelberg Engineering: Heidelberg Engineering is a leading manufacturer of retinal diagnostic imaging systems (Spectralis OCT/OCTA, HRT), making it the closest direct competitor to a Retinal Spectral Imaging System targeting the same ophthalmic specialists and indications.
• Optos (Nikon): Optos produces ultra-widefield retinal imaging devices used for early detection of retinal disease, closely comparable to NeD's stated focus on early diagnosis of vision-threatening disease.
• CenterVue (iCare): CenterVue, now part of iCare, develops fundus and OCT-based retinal imaging systems for screening and diagnosis, making it a directly comparable peer in non-mydriatic and clinical retinal imaging.
• Optovue (Visionix / BioMérieux): Optovue pioneered OCT angiography (OCTA) and competes directly in spectral-domain and functional retinal imaging, addressing the same clinical workflow of detecting early retinal pathology.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/461305

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Next Dimension (NeD)